GENFIT
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GENFIT is a late-stage biopharmaceutical company dedicated to discovering and developing therapeutic and diagnostic solutions for patients with rare and life-threatening liver diseases. With a scientific heritage spanning over two decades, the company has established a diversified pipeline focused on conditions with high unmet medical needs. GENFIT is a leader in developing treatments for Acute-on-Chronic Liver Failure (ACLF) and its complications, such as Hepatic Encephalopathy. The company's R&D portfolio also includes programs for Cholangiocarcinoma (CCA) and Urea Cycle Disorders (UCD). A key achievement is the successful development of elafibranor for Primary Biliary Cholangitis (PBC), which is now being commercialized by a partner. In addition to therapeutics, GENFIT has a diagnostic franchise focusing on metabolic liver diseases (MASH/NASH) and ammonia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-10 07:45 |
Regulatory News Service
GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une…
|
French | 204.9 KB | ||
| 2025-11-10 07:45 |
Regulatory News Service
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Rege…
|
English | 223.5 KB | ||
| 2025-11-10 07:30 |
Regulatory News Service
GENFIT présente de nouvelles données précliniques prometteuses sur NTZ/G1090N d…
|
French | 315.9 KB | ||
| 2025-11-10 07:30 |
Regulatory News Service
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment …
|
English | 217.0 KB | ||
| 2025-09-22 22:00 |
Interim Report
Attestation de la personne responsable associée au rapport d'activité et financ…
|
French | 118.9 KB | ||
| 2025-06-17 20:30 |
Post-Annual General Meeting Information
GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025
|
French | 140.4 KB | ||
| 2025-06-17 20:30 |
Post-Annual General Meeting Information
GENFIT: June 17, 2025 Combined Shareholders Meeting Results
|
English | 140.0 KB | ||
| 2025-05-22 22:10 |
Quarterly Report
GENFIT Reports First Quarter 2025 Financial Information
|
English | 163.4 KB | ||
| 2025-05-22 22:10 |
Earnings Release
GENFIT : Information financière du premier trimestre 2025
|
French | 146.7 KB | ||
| 2025-05-20 22:10 |
Regulatory News Service
GENFIT to receive a €26.5 million milestone payment following the approval of p…
|
English | 143.6 KB | ||
| 2025-05-20 22:10 |
Regulatory News Service
GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l…
|
French | 137.3 KB | ||
| 2025-05-14 22:10 |
Environmental & Social Information
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year…
|
English | 793.3 KB | ||
| 2025-05-07 22:10 |
Pre-Annual General Meeting Information
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposi…
|
French | 129.1 KB | ||
| 2025-05-07 22:10 |
Pre-Annual General Meeting Information
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Prepa…
|
English | 135.6 KB | ||
| 2025-05-05 07:30 |
Environmental & Social Information
GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
|
French | 228.8 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
